TacticGem LLC

Monopar Therapeutics Inc. · 10% Owner

TacticGem LLC is listed in filings as 10% Owner at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Dec 17, 2024, including 1 public disclosure. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Dec 17, 2024. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.